Griffith, Obi L. http://orcid.org/0000-0002-0843-4271
Spies, Nicholas C.
Anurag, Meenakshi
Griffith, Malachi
Luo, Jingqin
Tu, Dongsheng
Yeo, Belinda
Kunisaki, Jason
Miller, Christopher A
Krysiak, Kilannin http://orcid.org/0000-0002-6299-9230
Hundal, Jasreet
Ainscough, Benjamin J http://orcid.org/0000-0001-8340-514X
Skidmore, Zachary L.
Campbell, Katie
Kumar, Runjun
Fronick, Catrina
Cook, Lisa
Snider, Jacqueline E.
Davies, Sherri http://orcid.org/0000-0002-7141-8354
Kavuri, Shyam M.
Chang, Eric C.
Magrini, Vincent
Larson, David E. http://orcid.org/0000-0001-7934-5906
Fulton, Robert S
Liu, Shuzhen
Leung, Samuel
Voduc, David
Bose, Ron
Dowsett, Mitch
Wilson, Richard K.
Nielsen, Torsten O.
Mardis, Elaine R
Ellis, Matthew J.
Funding for this research was provided by:
Susan G. Komen (CCR16380599, PG12220321)
U.S. Department of Defense (W81XWH-16-0538, W81XWH-16-0538)
Cancer Prevention and Research Institute of Texas (RR140033)
Article History
Received: 5 December 2017
Accepted: 5 July 2018
First Online: 4 September 2018
Change Date: 6 December 2018
Change Type: Update
Change Details: The original HTML version of this paper was updated shortly after publication, because the Supplementary Data file links connected to incorrect files. This has now been corrected in the HTML; the PDF version of the paper was correct from the time of publication.
Competing interests
: M.J.E., T.O.N., and E.R.M. report income on patents on the PAM50 intrinsic subtype algorithm. M.J.E. reports ownership in Bioclassifier LLC that licenses PAM50 patents to Nanostring for the Prosigna breast cancer prognostic test. Commercial platforms and algorithms were not used in the analyses reported in this paper. The remaining authors declare no competing interests.